125 related articles for article (PubMed ID: 3947392)
1. Autacoid binding to serum proteins. Interaction of platelet activating factor (PAF) with human serum alpha-1-acid glycoprotein (AAG).
McNamara PJ; Brouwer KR; Gillespie MN
Biochem Pharmacol; 1986 Feb; 35(4):621-4. PubMed ID: 3947392
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.
Chao W; Siafaka-Kapadai A; Hanahan DJ; Olson MS
Biochem J; 1989 Jul; 261(1):77-81. PubMed ID: 2775221
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F
Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974
[TBL] [Abstract][Full Text] [Related]
4. 1-O-alkyl-2-acetyl-sn-glycerol: a platelet-activating factor metabolite with biological activity in vascular smooth muscle cells.
Stoll LL; Figard PH; Yerram NR; Yorek MA; Spector AA
Cell Regul; 1989 Nov; 1(1):13-25. PubMed ID: 2519612
[TBL] [Abstract][Full Text] [Related]
5. Effect of the sialylation state of alpha 1-acid glycoprotein on propranolol binding.
Primozic S; McNamara PJ
J Pharm Sci; 1985 Apr; 74(4):473-5. PubMed ID: 3999012
[TBL] [Abstract][Full Text] [Related]
6. Effect of differentiation on platelet-activating factor metabolism in HL-60 cells.
Stoll LL; Yerram NR; Spector AA
J Cell Sci; 1991 Sep; 100 ( Pt 1)():145-52. PubMed ID: 1795022
[TBL] [Abstract][Full Text] [Related]
7. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J
J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649
[TBL] [Abstract][Full Text] [Related]
8. Estimation of platelet-activating factor receptors in the endometrium of the pregnant rabbit: regulation of ligand availability and catabolism by bovine serum albumin.
Kudolo GB; Harper MJ
Biol Reprod; 1990 Sep; 43(3):368-77. PubMed ID: 1703022
[TBL] [Abstract][Full Text] [Related]
9. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence studies of beta-adrenergic ligand binding to alpha 1-acid glycoprotein with 1-anilino-8-naphthalene sulfonate, isoprenaline, adrenaline and propranolol.
Johansen AK; Willassen NP; Sager G
Biochem Pharmacol; 1992 Feb; 43(4):725-9. PubMed ID: 1540225
[TBL] [Abstract][Full Text] [Related]
11. Specific binding sites for platelet activating factor in human lung tissues.
Hwang SB; Lam MH; Shen TY
Biochem Biophys Res Commun; 1985 Apr; 128(2):972-9. PubMed ID: 2986633
[TBL] [Abstract][Full Text] [Related]
12. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
[TBL] [Abstract][Full Text] [Related]
13. Translocation of exogenous platelet-activating factor and its lyso-compound through plasma membranes is a rate-limiting step for their metabolic conversions into alkylacylglycerophosphocholines in rabbit platelets and guinea-pig leukocytes.
Tokumura A; Tsutsumi T; Yoshida J; Tsukatani H
Biochim Biophys Acta; 1990 May; 1044(1):91-100. PubMed ID: 2340312
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
Ring PC; Seldon PM; Barnes PJ; Giembycz MA
Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E
Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor binding and metabolism during human platelet aggregation.
Valone FH
Thromb Res; 1988 Apr; 50(1):103-12. PubMed ID: 3400077
[TBL] [Abstract][Full Text] [Related]
17. MgATP has different inhibitory effects on the use of 1-acyl-lysophosphatidylcholine and lyso platelet-activating factor acceptors by neuronal nuclear acetyltransferase activities.
Baker RR; Chang H
Biochim Biophys Acta; 1998 Jun; 1392(2-3):351-60. PubMed ID: 9630721
[TBL] [Abstract][Full Text] [Related]
18. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
Tahraoui L; Floch A; Mondot S; Cavero I
Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of platelet-activating factor biosynthesis by adenosine and histamine in human neutrophils: involvement of cPLA2alpha and reversal by lyso-PAF.
Flamand N; Lefebvre J; Lapointe G; Picard S; Lemieux L; Bourgoin SG; Borgeat P
J Leukoc Biol; 2006 May; 79(5):1043-51. PubMed ID: 16501051
[TBL] [Abstract][Full Text] [Related]
20. Alpha 1-acid glycoprotein concentrations and propranolol binding in elderly patients with acute illness.
Paxton JW; Briant RH
Br J Clin Pharmacol; 1984 Nov; 18(5):806-10. PubMed ID: 6508990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
